T1	Participants 81 146	patients with unresectable squamous cell cancer of the esophagus.
T2	Participants 307 372	patients with unresectable squamous cell cancer of the esophagus.
T3	Participants 856 922	Between April 1999 and December 2005, 125 patients were randomised
